Navigation Links
Interim Data Announced for BIBF 1120 as Compared to bevacizumab in Combination Chemotherapy in Metastatic Colorectal Cancer
Date:9/27/2011

STOCKHOLM, Sept. 27, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced interim results from an exploratory clinical trial evaluating its investigational compound BIBF 1120 in patients with metastatic colorectal cancer (mCRC).  In this Phase I/II study of 126 patients comparing BIBF 1120 as first-line treatment to bevacizumab, both in combination with mFOLFOX6 (6th modified regimen of folinic acid [leucovorin], fluorouracil, and oxaliplatin), the progression-free survival (PFS) rate at 9 months was 63 percent (95% CI: 50%-75%) in the BIBF 1120 arm and 69% (95% CI: 53%-86%) in the bevacizumab arm.(1)  The median PFS was numerically similar between both groups at 10.6 months ([95% CI: 9.4-12.3] for the BIBF 1120 arm and [95% CI: 9.1-NA] for the bevacizumab arm).(2)

The study, presented at the Presidential Session of the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, also showed that the objective response rate (ORR), a measure of tumor shrinkage, was 61 percent in the BIBF 1120 arm and 54 percent in the bevacizumab arm.(1)

While both treatment arms showed similar safety profiles, a lower incidence of serious adverse events was seen in patients taking BIBF 1120 compared to those taking bevacizumab (34% vs. 54%).(2)  Adverse events (grade 3 or higher) experienced by at least 10 percent of patients in the BIBF 1120 and bevacizumab arms included neutropenia (32% vs. 24%), diarrhea (15% vs. 12%), neurotoxicity (14% vs. 10%), paresthesia (13% vs. 12%) and asthenia (11% vs. 10%).(1)  Patients receiving BIBF 1120 experienced a lower frequency of serious gastrointestinal adverse events than those receiving bevacizumab (12% vs. 29%).(2)

The study is ongoing in order to collect overall survival (OS) data. Phase III trials with larger patient populations will be considered to confirm these results and to further investigate the potential of BIBF 1120 in mCRC.

"The study results
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
5. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
8. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
9. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
10. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
11. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... BARCELONA, Spain , July 4, 2015 /PRNewswire/ ... to first-line chemotherapy for patients with unresectable metastatic ... Progression-Free Survival in that organ Patients ... spread only to the liver experienced the greatest ... from the addition of SIR-Spheres Y-90 resin microspheres ...
(Date:7/3/2015)... A global continuing medical education ... thyroid disorders in Latin America ... dedicated to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227033) ... Manage Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic ...
(Date:7/2/2015)... 2015 BGI a annoncé aujourd,hui que ... l,ADN situé à Hong Kong ... of Pathologists  (Collège des pathologistes américains, ou CAP). ... Kong constituent le premier laboratoire clinique ... certification du CAP en Chine, car il satisfait ...
Breaking Medicine Technology:New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency Room , the ... Manzanares, MD as the new Medical Director of its Frisco facility. , “We are ... Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Every year, ... 24-Hour Train-a-Thon where they provide members of the Red Deer community with free fitness ... day of fitness training, games, food, events and entertainment raised thousands of charity dollars ...
(Date:7/2/2015)... Richmond, VA (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... the 18th sweetFrog store located in the Lone Star State. The premium frozen yogurt chain ... , The store, which opened June 19 in the Village at Bachman Lake, is located ...
(Date:7/2/2015)... ... July 02, 2015 , ... The American Association ... of the Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. ... Act seeks to decrease drug overdose – especially of heroin and opioid medication ...
(Date:7/2/2015)... ... 02, 2015 , ... With summer in full swing, Americans are flocking to Canada’s many lakes ... spots for fishing in the world, and it’s easy to understand why. From the Pacific ... fish. , Recreational fishing is a huge industry, and Americans make up the vast ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3
... Molecular Biology Organization (EMBO) today announced Simon Boulton of ... as the winner of the 2011 EMBO Gold Medal. ... contributions of young researchers in the molecular life sciences. ... groundbreaking research on DNA repair mechanisms. The election committee ...
... (HealthDay News) -- New research finds that adults who suffered ... hay fever -- are nine times more likely to have ... findings are based on about 1,400 adults who have been ... Health Study. The study participants were assessed in 1968, when ...
... announced today the U.S. Department of Defense (DOD) Breast ... Congressionally Directed Medical Research Programs has awarded Silvia Formenti, ... of the Department of Radiation Oncology a $4.5 million ... "This Multi-Team Award offers tremendous promise for new ...
... -- About 1 in 8 children infected with HIV ... resistant to multiple drugs -- within five years of ... drug failure rate is higher than in adults and ... young patients who begin antiretroviral therapy so early in ...
... TUESDAY, April 19 (HealthDay News) -- Certain gene mutations ... if that advice runs counter to experience, say researchers ... 70 volunteers with and without gene mutations that affect ... of the brain called the prefrontal cortex and the ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, April ... years for the diagnosis of Alzheimer,s disease could double the ... The guidelines, issued Tuesday by the Alzheimer,s Association and the ... from the last recommendations, which have been in use since ...
Cached Medicine News:Health News:EMBO Gold Medal 2011 awarded to Simon Boulton 2Health News:EMBO Gold Medal 2011 awarded to Simon Boulton 3Health News:Kids' Eczema, Hay Fever Linked to Allergic Asthma Later 2Health News:NYU Langone Medical Center awarded $4.5 million for breast cancer research 2Health News:Children With HIV at Higher Risk of Drug Resistance 2Health News: Alzheimer's Cases Could Double With New Guidelines: Expert 2Health News: Alzheimer's Cases Could Double With New Guidelines: Expert 3
... performance and value., ,The Aestiva/5 7100 ... the Aestiva/5 anesthesia system (open architecture, integrated ... newest anesthesia ventilation platform - the 7100 ... engineered to allow for ventilation of a ...
... ventilation., ,The Aestiva/5 offers exceptional capabilities ... to anesthesia therapy., ,The Aestiva/5 with ... intensive care ventilator, saving you the cost ... the OR. Its flexible ergonomic design and ...
... An integrated approach to quality patient care., ... an innovative approach to anesthesia delivery. As ... combines enhanced ventilation features, electronically controlled gas ... and information management to create a truly ...
... FlexiGel Strands® Absorbent Wound Dressing is a sterile, ... in moist wound dressing applications. The synthetic ... to the wound contours, and entraps slough and ... debridement. The strands of the matrix are ...
Medicine Products: